Tributyltin chloride leads to adiposity and impairs metabolic functions in the rat liver and pancreas

Toxicology Letters

Volumn 235, Issue 1, 2015, Pages 45-59

  Bertuloso, Bruno D ^a   Podratz, Priscila L ^a   Merlo, Eduardo ^a   de Araújo, Julia F P ^a   Lima, Leandro C F ^b   de Miguel, Emilio C ^c   de Souza, Leticia N ^a   Gava, Agata L ^a   de Oliveira, Miriane ^d   Miranda Alves, Leandro ^e   Carneiro, Maria T W D ^a   Nogueira, Celia R ^d   Graceli, Jones B ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiposity; Inflammation; Insulin; Liver; Pancreas; TBT chloride

Indexed keywords

ESTROGEN RECEPTOR ALPHA; FAT DROPLET; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIBUTYLTIN CHLORIDE; ENDOCRINE DISRUPTOR; GLUCOSE BLOOD LEVEL; ORGANOTIN COMPOUND; POLLUTANT; TRIBUTYLTIN;

3T3 CELL LINE; ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GLUCOSE TOLERANCE; HEPATITIS; INFLAMMATION; INSULIN SENSITIVITY; LIPID STORAGE; LIVER; METABOLIC DISORDER; NONHUMAN; OBESITY; PANCREAS; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ADIPOGENESIS; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; FATTY LIVER; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MOUSE; PATHOPHYSIOLOGY; POLLUTANT; TIME; TOXICITY; WHITE ADIPOCYTE; WISTAR RAT;

ANIMALIA; RATTUS;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ADIPOGENESIS; ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; BLOOD GLUCOSE; DRUG-INDUCED LIVER INJURY; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; ESTROGEN RECEPTOR ALPHA; FATTY LIVER; FEMALE; INSULIN; ISLETS OF LANGERHANS; LIVER; MICE; PANCREAS; PPAR GAMMA; RATS, WISTAR; TIME FACTORS; TRIALKYLTIN COMPOUNDS; WEIGHT GAIN;

EID: 84925872505     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2015.03.009     Document Type: Article

References (95)

1. Ahima R.S. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 2006, 14:242S-249S. 10.1038/oby.2006.317.
2. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 2006, 114:106-112. 10.1289/ehp.8451.
3. Altintas M.M., Azad A., Nayer B., Contreras G., Zaias J., Faul C., Reiser J., Nayer N.A. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J. Lipid Res. 2011, 52:480-488. 10.1194/jlr.M011338.
4. Anwar A., McTernan P.G., Anderson L.A., Askaa J., Moody C.G., Barnett A.H., Eggo M.C., Kumar S. Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue. Diabetes Obes. 2001, 3:338-349. 10.1046/j.1463-1326.2001.00145.x.
5. Arzi B., Murphy B., Cox D.P., Vapniarsky N., Kass P.H., Verstraete F.J. Presence and quantification of mast cells in the gingiva of cats with tooth resorption, periodontitis and chronic stomatitis. Arch. Oral Biol. 2010, 55:148-154. 10.1016/j.archoralbio.2009.11.004.
6. Appel K.E. Organotin compounds: toxicokinetic aspects. Drug Metab. Rev. 2004, 36(3-4):763-786. 10.1081/DMR-200033490.
7. Badman M.K., Flier J.S. The gut and energy balance: visceral allies in the obesity wars. Science 2005, 307:1909-1914. 10.1126/science.1109951.
8. Baptista L.S., da Silva K.R., da Pedrosa C.S., Claudio-da-Silva C., Carneiro J.R., Aniceto M., de Mello-Coelho V., Takiya C.M., Rossi M.I., Borojevic R. Adipose tissue of control and ex-obese patients exhibit differences in blood vessel content and resident mesenchymal stem cell population. Obes. Surg. 2009, 19:1304-1312. 10.1007/s11695-009-9899-2.
9. Barnes J.M., Stoner H.B. The toxicology of tin compounds. Pharmacol. Rev. 1959, 11:211-231.
10. Bieghs V., Verheyen F., van Gorp P.J., Hendrikx T., Wouters K., Lütjohann D., Gijbels M.J., Febbraio M., Binder C.J., Hofker M.H., Shiri-Sverdlov R. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. PLoS One 2012, 7:e34378. 10.1371/journal.pone.0034378.
11. Bieghs V., Trautwein C. The innate immune response during liver inflammation and metabolic disease. Trends Immunol. 2013, 34:446-452. 10.1016/j.it.2013.04.005.
12. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
13. Brenner C., Galluzzi L., Kepp O., Kroemer G. Decoding cell death signals in liver inflammation. J. Hepatol. 2013, 59:583-594. 10.1016/j.jhep.2013.03.033.
14. Bryzgalova G., Gao H., Ahren B., Zierath J.R., Galuska D., Steiler T.L., Dahlman-Wright K., Nilsson S., Gustafsson J.A., Efendic S., Khan A. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 2006, 49:588-597. 10.1007/s00125-005-0105-3.
15. Bryzgalova G., Lundholm L., Portwood N., Gustafsson J.A., Khan A., Efendic S., Dahlman-Wright K. Mechanisms of antidiabetogenic and body weightlowering effects of estrogen in high-fat diet-fed mice. Am. J. Physiol. Endocrinol. 2008, 295:904-912. 10.1152/ajpendo.90248.2008.
16. Chamorro-García R., Sahu M., Abbey R.J., Laude J., Pham N., Blumberg B. Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environ. Health Perspect. 2013, 121(3):359-366. 10.1289/ehp.1205701.
17. Cooke P.S., Naaz A. Role of estrogens in adipocyte development and function. Exp. Biol. Med. (Maywood) 2004, 229:1127-1135.
18. Couse J.F., Lindzey J., Grandien K., Gustafsson J.A., Korach K.S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997, 138:4613-4621. 10.1210/endo.138.11.5496.
19. Danilovich N., Babu P.S., Xing W., Gerdes M., Krishnamurthy H., Sairam M.R. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 2000, 141:4295-4308. 10.1210/endo.141.11.7765.
20. Dang Z., Löwik C.W. The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J. Bone Miner Res. 2004, 19(5):853-861.
21. de Cock M., van de Bor M. Obesogenic effects of endocrine disruptors, what do we know from animal and human studies?. Environ. Int. 2014, 70:15-24. 10.1016/j.envint.2014.04.022.
22. de Oliveira M., Luvizotto A., Rde, Olimpio R.M., De Sibio M.T., Conde S.J., Biz Rodrigues Silva C., Moretto F.C., Nogueira C.R. Triiodothyronine increases mRNA and protein leptin levels in short time in 3T3-L1 adipocytes by PI3K pathway activation. PLoS One 2013, 18(8(9)):e74856. 10.1371/journal.pone.0074856.
23. Dorneles P.R., Lailson-Brito J., Fernandez M.A., Vidal L.G., Barbosa L.A., Azevedo A.F., Fragoso A.B., Torres J.P., Malm O. Evaluation of cetacean exposure to organotin compounds in Brazilian waters through hepatic total tin concentrations. Environ. Pollut. 2008, 156(3):1268-1276. 10.1016/j.envpol.2008.03.007.
24. dos Santos R.L., Podratz P.L., Sena G.C., Filho V.S., Lopes P.F., Gonçalves W.L., Alves L.M., Samoto V.Y., Takiya C.M., de Castro Miguel E., Moysés M.R., Graceli J.B. Tributyltin impairs the coronary vasodilation induced by 17β-estradiol in isolated rat heart. J. Toxicol. Environ. Health A 2012, 75:948-959. 10.1080/15287394.2012.695231.
25. Evans M.J., Lai K., Shaw L.J., Harnish D.C., Chadwick C.C. Estrogen receptor alpha inhibits IL-1beta induction of gene expression in the mouse liver. Endocrinology 2002, 143:2559-2570. 10.1210/endo.143.7.8919.
26. Fent K. Ecotoxicology of organotin compounds. Crit. Rev. Toxicol. 1996, 26:1-117. 10.3109/10408449609089891.
27. Gao H., Fält S., Sandelin A., Gustafsson J.A., Dahlman-Wright K. Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver. Mol. Endocrinol. 2008, 22:10-22. 10.1210/me2007-0121.
28. Gimeno R.E., Klaman L.D. Adipose tissue as an active endocrine organ: recent advances. Curr. Opin. Pharmacol. 2005, 5:122-128. 10.1016/j.coph.2005.01.006.
29. Godsland I.F. Oestrogens and insulin secretion. Diabetologia. 2005, 48:2213-2220. 10.1007/s00125-005-1930-0.
30. Graceli J.B., Sena G.C., Lopes P.F., Zamprogno G.C., da Costa M.B., Godoi A.F., Dos Santos D.M., de Marchi M.R., Dos Santos Fernandez M.A. Organotins: a review of their reproductive toxicity, biochemistry, and environmental fate. Reprod. Toxicol. 2013, 36:40-52. 10.1016/j.reprotox.2012.11.008.
31. Gracelli J.B., Souza-Menezes J., Barbosa C.M., Ornellas F.S., Takiya C.M., Alves L.M., Wengert M., Feltran S., Gda, Caruso-Neves C., Moyses M.R., Prota L.F., Morales M.M. Role of estrogen and progesterone in the modulation of CNG-A1 and Na/K+-ATPase expression in the renal cortex. Cell Physiol. Biochem. 2012, 30:160-172. 10.1159/000339055.
32. Grondin M., Marion M., Denizeau F., Averill-Bates D.A. Tributyltin induces apoptotic signaling in hepatocytes through pathways involving the endoplasmic reticulum and mitochondria. Toxicol. Appl. Pharmacol. 2007, 222(1):57-68. 10.1016/j.taap.2007.03.028.
33. Grote K., Andrade A.J., Grande S.W., Kuriyama S.N., Talsness C.E., Appel K.E., Chahoud I. Effects of peripubertal exposure to triphenyltin on female sexual development of the rat. Toxicology 2006, 222:17-24. 10.1016/j.tox.2006.01.008.
34. Grün F., Watanabe H., Zamanian Z., Maeda L., Arima K., Cubacha R., Gardiner D.M., Kanno J., Iguchi T., Blumberg B. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol. Endocrinol. 2006, 20:2141-2155. 10.1210/me2005-0367.
35. Grün F., Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006, 147:50-55. 10.1210/en2005-1129.
36. Grün F., Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev. Endocr. Metab. Disord. 2007, 8:161-171. 10.1007/s11154-007-9049-x.
37. Guerre-Millo M. Adipose tissue hormones. J. Endocrinol. Invest. 2002, 25:855-861.
38. Heber D. An integrative view of obesity. Am. J. Clin. Nutr. 2010, 91:280-283. 10.1007/BF03344048.
39. Heindel J.J., vom Saal F.S. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol. Cell Endocrinol. 2009, 304:90-96. 10.1016/j.mce.2009.02.025.
40. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12729-12734. 10.1073/pnas.97.23.12729.
41. Homma H., Kurachi H., Nishio Y., Takeda T., Yamamoto T., Adachi K., Morishige K., Ohmichi M., Matsuzawa Y., Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene Existence of a unique estrogen response element on the lipoprotein lipase promoter. J. Biol. Chem. 2000, 275:11404-11411. 10.1074/jbc.275.15.11404.
42. International Maritime Organization (IMO). 2001. International Convention on the Control of Harmful Anti-fouling Systems on Ships. Available:. http://www.imo.org.
43. Johnson A.R., Milner J.J., Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol. Rev. 2012, 249:218-238. 10.1111/j.1600-065X.2012.01151.x.
44. Keller H., Givel F., Perroud M., Wahli W. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol. Endocrinol. 1995, 9:794-804. 10.1210/mend.9.7.7476963.
45. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. 2004, 89:2548-2556. 10.1210/jc.2004-0395.
46. Kirchner S., Kieu T., Chow C., Casey S., Blumberg B. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol. Endocrinol. 2010, 24:526-539. 10.1210/me. 2009-0261.
47. Kletzien R.F., Foellmi L.A., Harris P.K., Wyse B.M., Clarke S.D. Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent. Mol. Pharmacol. 1992, 42:558-562.
48. Korach K.S. Estrogen receptor knock-out mice: molecular and endocrine phenotypes. J. Soc. Gynecol. Investig. 2000, 7:16-17. 10.1177/107155760000700106.
49. Krajnc E.I., Wester P.W., Loeber J.G., van Leeuwen F.X., Vos J.G., Vaessen H.A., van der Heijden C.A. Toxicity of bis(tri-n-butyltin) oxide in the rat. I. Short-term effects on general parameters and on the endocrine and lymphoid systems. Toxicol. Appl. Pharmacol. 1984, 30(75(3)):363-386. 10.1016/0041-008X(84)90176-5.
50. Lang Podratz P., Delgado Filho V.S., Lopes P.F., Cavati Sena G., Matsumoto S.T., Samoto V.Y., Takiya C.M., de Castro Miguel E., Silva I.V., Graceli J.B. Tributyltin impairs the reproductive cycle in female rats. J. Toxicol. Environ. Health A 2012, 75:1035-1046. 10.1080/15287394.2012.697826.
51. Lee C.C., Wang T., Hsieh C.Y., Tien C.J. Organotin contamination in fishes with different living patterns and its implications for human health risk in Taiwan. Environ. Pollut. 2005, 137:198-208. 10.1016/j.envpol.2005.02.011.
52. Leitman D.C., Paruthiyil S., Yuan C., Herber C.B., Olshansky M., Tagliaferri M., Cohen I., Speed T.P. Tissue-specific regulation of genes by estrogen receptors. Semin. Reprod. Med. 2012, 30:14-22. 10.1055/s-0031-1299593.
53. Lemieux C., Phaneuf D., Labrie F., Giguère V., Richard D., Deshaies Y. Estrogen receptor alpha-mediated adiposity-lowering and hypocholesterolemic actions of the selective estrogen receptor modulator acolbifene. Int. J. Obes. (Lond.) 2005, 29:1236-1244. 10.1038/sj.ijo.0803014.
54. Liu H.G., Wang Y., Lian L., Xu L.H. Tributyltin induces DNA damage as well as oxidative damage in rats. Environ. Toxicol. 2006, 21:166-171. 10.1002/tox.20170.
55. Liu J., Divoux A., Sun J., Zhang J., Clément K., Glickman J.N., Sukhova G.K., Wolters P.J., Du J., Gorgun C.Z., Doria A., Libby P., Blumberg R.S., Kahn B.B., Hotamisligil G.S., Shi G.P. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009, 15:940-945. 10.1038/nm.1994.
56. Ludgero-Correia A., Aguila M.B., Mandarim-de-Lacerda C.A., Faria T.S. Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice. Nutrition 2012, 28(3):316-323. 10.1016/j.nut.2011.07.014.
57. Lundholm L., Bryzgalova G., Gao H., Portwood N., Fält S., Berndt K.D., Dicker A., Galuska D., Zierath J.R., Gustafsson J.A., Efendic S., Dahlman-Wright K., Khan A. The estrogen receptor alpha-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms. J. Endocrinol. 2008, 199:275-286. 10.1677/JOE-08-0192.
58. MacLaren R., Cui W., Cianflone K. Adipokines and the immune system: an adipocentric view. Adv. Exp. Med. Biol. 2008, 632:1-21.
59. Maron-Gutierrez T., Castiglione R.C., Xisto D.G., Oliveira M.G., Cruz F.F., Peçanha R., Carreira-Junior H., Ornellas D.S., Moraes M.O., Takiya C.M., Rocco P.R., Morales M.M. Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis. Eur. Respir. J. 2011, 37:1217-1225. 10.1183/09031936.00205009.
60. Medlock K.L., Forrester T.M., Sheehan D.M. Short-term effects of physiological and pharmacological doses of estradiol on estrogen receptor and uterine growth. J. Recept. Res. 1991, 11(5):743-756.
61. Medlock K.L., Forrester T.M., Sheehan D.M. Progesterone and estradiol interaction in the regulation of rat uterine weight and estrogen receptor concentration. Proc. Soc. Exp. Biol. Med. 1994, 205(2):146-153.
62. Monget P., Chabrolle C., Dupont J. Adipose tissue, nutrition and reproduction: what is the link?. Bull. Acad. Natl. Med. 2008, 192:637-648.
63. Mohamed M.K., Abdel-Rahman A.A. Effect of long-term ovariectomy and estrogen replacement on the expression of estrogen receptor gene in female rats. Eur. J. Endocrinol. 2000, 142(3):307-314.
64. Mu Y.M., Yanase T., Nishi Y., Takayanagi R., Goto K., Nawata H. Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol. Cell Endocrinol. 2001, 181(1-2):239-248.
65. Mu Y.M., Yanase T., Nishi Y., Waseda N., Oda T., Tanaka A., Takayanagi R., Nawata H. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Biochem. Biophys. Res. Commun. 2000, 271(3):710-713.
66. Murata Y., Robertson K.M., Jones M.E., Simpson E.R. Effect of estrogen deficiency in the male: the ArKO mouse model. Mol. Cell Endocrinol. 2002, 193(1-2):7-12.
67. Nagira K., Sasaoka T., Wada T., Fukui K., Ikubo M., Hori S., Tsuneki H., Saito S., Kobayashi M. Altered subcellular distribution of estrogen receptor alpha is implicated in estradiol-induced dual regulation of insulin signaling in 3T3-L1 adipocytes. Endocrinology 2006, 147:1020-1028. 10.1210/en2005-0825.
68. Navab M., Gharavi N., Watson A.D. Inflammation and metabolic disorders. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11:459-464. 10.1097/MCO.0b013e32830460c2.
69. Newbold R.R., Padilla-Banks E., Jefferson W.N. Environmental estrogens and obesity. Mol. Cell Endocrinol. 2009, 304:84-89. 10.1016/j.mce.2009.02.024.
70. Oberdõrster E., McClellan-Green P. Mechanisms of imposex induction in the mud snail Ilyanassa obsoleta: TBT as a neurotoxin and aromatase inhibitor. Mar. Environ. Res. 2002, 54:715-718. 10.1016/S0141-1136(02)118-6.
71. Okubo T., Suzuki T., Yokoyama Y., Kano K., Kano I. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol. Pharm. Bull. 2003, 26:1219-1224. 10.1248/bpb.26.1219.
72. Pallottini V., Bulzomi P., Galluzzo P., Martini C., Marino M. Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms. Infect. Disord. Drug Targets 2008, 8:52-60. 10.2174/187152608784139631.
73. Penza M., Jeremic M., Marrazzo E., Maggi A., Ciana P., Rando G., Grigolato P.G., Di Lorenzo D. The environmental chemical tributyltin chloride (TBT) shows both estrogenic and adipogenic activities in mice which might depend on the exposure dose. Toxicol. Appl. Pharmacol. 2011, 255:65-75. 10.1016/j.taap.2011.05.017.
74. Penza M., Montani C., Romani A., Vignolini P., Pampaloni B., Tanini A., Brandi M.L., Alonso-Magdalena P., Nadal A., Ottobrini L., Parolini O., Bignotti E., Calza S., Maggi A., Grigolato P.G., Di Lorenzo D. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 2006, 147(12):5740-5751.
75. Rodrigues S.M., Ximenes C.F., de Batista P.R., Simões F.V., Coser P.H., Sena G.C., Podratz P.L., de Souza L.N., Vassallo D.V., Graceli J.B., Stefanon I. Tributyltin contributes in reducing the vascular reactivity to phenylephrine in isolated aortic rings from female rats. Toxicol. Lett. 2014, 225:378-385. 10.1016/j.toxlet.2014.01.002.
76. Rosen E.D., Walkey C.J., Puigserver P., Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev. 2000, 14:1293-1307. 10.1101/gad.14.11.1293.
77. Saitoh M., Yanase T., Morinaga H., Tanabe M., Mu Y.M., Nishi Y., Nomura M., Okabe T., Goto K., Takayanagi R., Nawata H. Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell line KGN. Biochem. Biophys. Res. Commun. 2001, 23(289(1)):198-204.
78. Santos S.H., Braga J.F., Mario E.G., Pôrto L.C., Rodrigues-Machado G., Mda, Murari A., Botion L.M., Alenina N., Bader M., Santos R.A. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7). Arterioscler. Thromb. Vasc. Biol. 2010, 30:953-961. 10.1161/ATVBAHA.109.200493.
79. Sharan S., Nikhil K., Roy P. Effects of low dose treatment of tributyltin on the regulation of estrogen receptor functions in MCF-7 cells. Toxicol. Appl. Pharmacol. 2013, 269:176-186. 10.1016/j.taap.2013.03.009.
80. Shi H., Seeley R.J., Clegg D.J. Sexual differences in the control of energy homeostasis. Front Neuroendocrinol. 2009, 30:396-404. 10.1016/j.yfrne.2009.03.004.
81. Solinas G., Karin M. JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction. FASEB J. 2010, 24(8):2596-2611. 10.1096/fj. 09-151340.
82. Song R.X., Barnes C.J., Zhang Z., Bao Y., Kumar R., Santen R.J. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2076-2081. 10.1073/pnas.0308334100.
83. Suzuki T., Hayashi S., Miki Y., Nakamura Y., Moriya T., Sugawara A., Ishida T., Ohuchi N., Sasano H. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Endocr. Relat. Cancer 2006, 13:233-250. 10.1677/erc.1.01075.
84. Tafuri S.R. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. Endocrinology 1996, 137:4706-4712. 10.1210/endo.137.11.8895337.
85. Tchernof A., Poehlman E.T., Després J.P. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab. 2000, 26:12-20. DM-03-2000-26-1-1262-3636-101019-ART66.
86. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156. 10.1016/0092-8674(94)90006-X.
87. Ueno S., Susa N., Furukawa Y., Sugiyama M. Comparison of hepatotoxicity caused by mono-, di- and tributyltin compounds in mice. Arch. Toxicol. 1994, 69:30-34. 10.1007/s002040050133.
88. Wang X., Kilgore M.W. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol. Cell Endocrinol. 2002, 194:123-133. 10.1016/S0303-7207(02)154-5.
89. Wiebkin P., Prough R.A., Bridges J.W. The metabolism and toxicity of some organotin compounds in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 1982, 15(62(3)):409-420.
90. Xiao J., Wang N.L., Sun B., Cai G.P. Estrogen receptor mediates the effects of pseudoprotodiocsin on adipogenesis in 3T3-L1 cells. Am. J. Physiol. Cell Physiol. 2010, 299:128-138. 10.1152/ajpcell.00538.2009.
91. Yamabe N., Kang K.S., Zhu B.T. Beneficial effect of 17b-estradiol on hyperglycemia and islet b-cell functions in a streptozotocin-induced diabetic rat model. Toxicol. Appl. Pharmacol. 2010, 249:76-85. 10.1016/j.taap.2010.08.020.
92. Yepuru M., Eswaraka J., Kearbey J.D., Barrett C.M., Raghow S., Veverka K.A., Miller D.D., Dalton J.T., Narayanan R. Estrogen receptor-β-selective ligands alleviate high-fat diet and ovariectomy-induced obesity in mice. J. Biol. Chem. 2010, 285:31292-31303. 10.1074/jbc.M110.147850.
93. Yu I.C., Lin H.Y., Liu N.C., Sparks J.D., Yeh S., Fang L.Y., Chen L., Chang C. Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-κB-mediated PTP1B expression. Diabetes 2013, 62:411-423. 10.2337/db12-0135.
94. Zhou C.H., Li M.L., Qin A.L., Lv S.X., Wen-Tang, Zhu X.Y., Li L.Y., Dong Y., Hu C.Y., Hu D.M., Wang S.F. Reduction of fibrosis in dibutyltin dichloride-induced chronic pancreatitis using rat umbilical mesenchymal stem cells from Wharton's jelly. Pancreas 2013, 42(8):1291-1302. 10.1097/MPA.0b013e318296924e.
95. Zuo Z., Chen S., Wu T., Zhang J., Su Y., Chen Y., Wang C. Tributyltin causes obesity and hepatic steatosis in male mice. Environ. Toxicol. 2011, 26:79-85. 10.1002/tox.20531.